BH4-mimetics and -antagonists: an emerging class of Bcl-2 protein modulators for cancer therapy
Oncotarget
.
2018 Oct 19;9(82):35291-35292.
doi: 10.18632/oncotarget.26250.
Authors
Adrien Nougarède
1
,
Ruth Rimokh
1
,
Germain Gillet
1
Affiliation
1
Univ Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, Lyon, France.
PMID:
30450157
PMCID:
PMC6219674
DOI:
10.18632/oncotarget.26250
No abstract available
Keywords:
BH4 domain; Bcl-2 proteins; apoptosis; cancer; therapy.
Publication types
Editorial